Drug Approval | December 08, 2023
Novartis receives FDA approval for Fabhalta as the first oral monotherapy for adults with PNH
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
India had proposed for setting up the global standards for millets
Subscribe To Our Newsletter & Stay Updated
